Connect with us

Technology

Velo3D Announces Third Quarter 2026 Financial Results

Published

on

Revenue of $20.5 million, up 50% year-over-yearNew bookings of $28.9 million Gross margin of 26.5%Cash and cash equivalents of $75.7 million as of September 30, 2026Reaffirms 2026 Revenue Guidance; Revises 2026 Gross Margin Guidance; Reduces 2026 Capital Expenditures Guidance; Now Expects Positive Net Cash from Operations in 2028

FREMONT, Calif., Nov. 10, 2026 /PRNewswire/ — Velo3D, Inc. (Nasdaq: VELO) (“Velo3D” or the “Company”), a leading metal additive manufacturing (“AM”) technology company focused on aerospace and defense supply chains, today announced financial results for its third quarter ended September 30, 2026.  

Arun Jeldi, Chief Executive Officer of Velo3D, said, “We delivered solid third quarter results, with revenue increasing approximately 50% year-over-year to $20.5 million and new bookings reaching $28.9 million, exceeding revenue for the quarter. These results reflect continued customer demand for our metal additive manufacturing technology and the progress we are making in executing our growth strategy. Operating expenses increased as we continued investing in the people, technology and operational capabilities needed to bring our Livermore Production Campus, Forge 1, online and prepare for expanded production. We believe these investments are an important step in positioning Velo3D to scale operations and meet customer demand.

Looking ahead, Forge 1 is central to Velo3D’s next phase of growth and is expected to significantly expand our production capacity as it becomes fully operational, enabling us to pursue larger production programs and capture opportunities across aerospace, defense, space and energy. While a substantial portion of our planned capital expenditures is shifting into 2027, we believe these investments in infrastructure, talent and manufacturing capabilities are essential to scaling our operations, strengthening execution and building the foundation for sustainable, profitable growth.”

Recent Business Developments

Opened the new Livermore Production Campus, Forge 1 in July 2026. The campus has commenced operations in phases and is not yet operating at scale. It is expected to significantly expand the Company’s manufacturing production capacity as it is brought to full operation, and to support demand from aerospace and defense customers for the Company’s metal additive manufacturing solutions. The Company expects Forge 1 to serve as its  primary production and manufacturing center.Joined the Government-Industry Data Exchange Program (GIDEP) to further strengthen quality, reliability and supply-chain risk management for defense manufacturing activities, providing access to critical technical and quality information that supports risk mitigation and the production of mission-critical components for U.S. defense programs.Expanded partnership with Mears Machine Corporation as Mears ordered its sixth Sapphire® XC system, dedicated to copper-nickel (CuNi) additive manufacturing. The system expands Velo3D’s production platform into a material critical to shipbuilding and offshore applications, enabling U.S.-based production of corrosion-resistant components.Expanded technology and operational capabilities with the appointments of Vic Fryzel as Executive Vice President, Technology, and Robert Purnell as Senior Director, Operations, to advance platform reliability, manufacturing readiness, quality and delivery performance at Forge 1, supporting scalable production and Velo3D’s Rapid Production Solutions offering.

($ in Millions, except percentages and per-share data)

3rd Quarter 2026

3rd Quarter 2025

GAAP revenue

$20.5

$13.6

GAAP gross margin

26.5 %

3.2 %

GAAP net loss1

($16.7)

($11.2)

GAAP net loss per share  – basic and diluted

($0.52)

($0.65)

Non-GAAP net loss1,2

($10.8)

($9.3)

Non-GAAP net loss per share  – basic and diluted1,2

($0.34)

($0.54)

Information about Velo3D’s use of non-GAAP information, including a reconciliation to accounting principles generally accepted in the United States of America (“GAAP”), is provided at the end of this release under “Non-GAAP Financial Information”. The non-GAAP financial measures presented in this release should not be considered as the sole measure of the Company’s performance and should not be considered in isolation from, or as a substitute for, comparable financial measures calculated in accordance with GAAP.

Non-GAAP net loss and non-GAAP net loss per basic and diluted share exclude stock-based compensation expense, loss on warrant cancellation, and fair value adjustments for the Company’s warrants and earnout liability.

Summary of Third Quarter 2026 Results  

Total revenue was $20.5 million. 3D Printer and parts revenue was $18.8 million and increased 57.0% compared to $12.0 million in the third quarter of 2025. This increase was driven by an increase in the number of 3D Printer systems sold, higher average selling prices and a more favorable product mix, as well as an increase in RPS revenue driven by higher production volume during the three months ended September 30, 2026, compared to the three months ended September 30, 2025. 

Gross margin for the third quarter was 26.5% compared to 3.2% in the third quarter of 2025. Gross profit and gross margin improved primarily due to higher average selling prices, a more favorable product mix, improved manufacturing efficiencies and increased production volumes that improved the absorption of fixed manufacturing costs, a net release of excess and obsolete inventory reserves in the current period, reflecting the utilization in production of previously reserved inventory, partially offset by increases in reserves for other inventory. Results also benefited from the prospective refinement in the allocation of certain labor and overhead costs between cost of revenue and operating expenses, implemented in the second quarter of 2026 to better align such costs with current operational activities.

Operating expenses for the third quarter were $22.7 million compared to $10.4 million in the third quarter of 2025. Non-GAAP adjusted operating expenses, excluding stock-based compensation recorded in operating expenses of $5.7 million, were $17.0 million, up from $9.1 million in the third quarter of 2025.  

GAAP net loss for the third quarter was ($16.7) million, or ($0.52) per basic and diluted share, compared to ($11.2) million, or ($0.65) per basic and diluted share in the third quarter of 2025. 

Non-GAAP net loss for the third quarter was ($10.8) million compared to ($9.3) million in the third quarter of 2025. Adjusted EBITDA for the third quarter was ($9.8) million compared to ($7.3) million in the third quarter of 2025. For more information regarding the Company’s non-GAAP financial measures, including reconciliations to the most directly comparable GAAP measures,  see “Non-GAAP Financial Information” below.

The Company had $28.9 million in new bookings during the third quarter and backlog of $40.1 million as of September 30, 2026.

As of September 30, 2026, the Company had $75.7 million of cash and cash equivalents, compared to $39.0 million as of December 31, 2025. The increase was driven primarily by net cash provided by financing activities of approximately $98.6 million during the first nine months of 2026, partially offset by approximately $52.2 million of cash used in operating activities and approximately $6.4 million of cash used in investing activities. In April 2026, the Company completed a firm commitment underwritten registered direct offering of 3,571,428 shares of its common stock, resulting in gross proceeds of approximately $50 million (approximately $46.6 million net of issuance costs). The Company also raised gross proceeds of approximately $59.4 million during the second quarter under its at-the-market offering program (approximately $57.4 million net of issuance costs). As a result of the conversion of the Company’s convertible secured notes into common stock in March 2026, the repayment in full of its Secured Notes and scheduled repayments under its equipment loan,  the Company’s total outstanding debt decreased by approximately 76% to $7.4 million as of September 30, 2026,  from $31.0 million as of December 31, 2025.  

In connection with the preparation of its financial statements for the third quarter of 2026, management evaluated the Company’s ability to continue as a going concern and concluded that there is no longer substantial doubt about the Company’s ability to continue as a going concern for the twelve months following the issuance of its third quarter 2026 financial statements. Management’s assessment does not assume that additional financing is required to fund operations or satisfy obligations during that period. Additional information will be included in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026.

Guidance

Management is reaffirming its full-year 2026 revenue and non-GAAP adjusted operating expense guidance, is revising its gross margin guidance and reducing its capital expenditure outlook, and is providing an expected timeline for achieving positive net cash from operations and an updated expected timeline for achieving positive EBITDA as follows:

Revenue in the range of $65 million to $75 million.Sequential improvement in gross margin in the fourth quarter of 2026. The Company is no longer providing its prior expectation of greater than 30% gross margin in the second half of 2026.Non-GAAP adjusted operating expenses in the range of $45 million to $55 million.Capital expenditures in the range of $10 million to $20 million,  reduced from the Company’s prior expectation of $40 million to $50 million, primarily reflecting the shift of a substantial portion of planned capital expenditures into 2027.Positive net cash from operations and positive EBITDA in 2028, compared with the Company’s prior expectation of positive EBITDA in the second half of 2026.

Conference Call

The Company will host a conference call for investors to discuss its third quarter 2026 financial results at 2:00 p.m. Pacific time / 5:00 p.m. Eastern time on November 10, 2026. The call will be webcast and can be accessed from the Events page of the Investor Relations section of Velo3D’s website at ir.velo3d.com.

About Velo3D:

Velo3D is a metal 3D printing technology company that enables customers to build mission-critical metal parts. The fully integrated solution includes the Flow print preparation software, the Sapphire® family of printers, and the Assure quality control system—all of which are powered by Velo3D’s Intelligent Fusion® manufacturing process. Learn more at velo3d.com.

Velo, Velo3D, Sapphire and Intelligent Fusion are registered trademarks of Velo3D, Inc. Flow, Flow Developer, Without Compromise and Assure are trademarks of Velo3D, Inc.

Investor Relations:
Hayden IR
James Carbonara
investors@velo3d.com

Media Contact:
Velo3D
press@velo3d.com  

During the third quarter of 2026, the Company revised its previously issued unaudited condensed consolidated financial statements for the three months ended March 31, 2026 and the three and six months ended June 30, 2026 to correct errors related to its excess and obsolete inventory reserve. The revisions reduced the previously reported net loss for the six months ended June 30, 2026 by approximately $1.6 million. Nine-month 2026 amounts in this release reflect the revised amounts. See Note 2 to the condensed consolidated financial statements in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026.

Amounts herein pertaining to the Company’s third quarter ended September 30, 2026 results represent a preliminary estimate as of the date of this earnings release and may be revised upon filing of the Company’s Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission (the “SEC”). Additional information on the Company’s results of operations for the three and nine months ended September 30, 2026 will be provided upon the filing of its Quarterly Report on Form 10-Q with the SEC.

Forward-Looking Statements:

This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. The Company’s actual results may differ from its expectations, estimates and projections and consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect”, “estimate”, “project”, “budget”, “forecast”, “anticipate”, “intend”, “plan”, “may”, “will”, “could”, “should”, “believes”, “predicts”, “potential”, “continue”, and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, the Company’s guidance for fiscal year 2026 (including the Company’s estimates for revenue, gross margin, non-GAAP adjusted operating expenses and capital expenditures), the Company’s expectations regarding the timing and amount of its capital expenditures, including the shift of planned capital expenditures into 2027 and its ability to finance them, the Company’s expectations regarding its ability to achieve positive EBITDA and positive net cash provided by operating activities in 2028, management’s conclusion that conditions and events no longer raise substantial doubt about the Company’s ability to continue as a going concern for the twelve months following issuance of its third quarter 2026 financial statements, the Company’s expectations regarding the remediation of the remaining material weaknesses in its internal control over financial reporting, the Company’s expectations about future demand, growth, profitability, long-term value, capacity requirements and operational efficiencies, scaled production, pipeline of opportunities, customer priorities, gross margins, the Company’s expectations regarding its liquidity and capital requirements, including any plans to raise additional capital to support its expansion and the potential sources and uses of that capital, and the Company’s beliefs regarding its ability to execute on strategic initiatives, scale operations, achieve sustainable, profitable growth and capitalize on demand, the Company’s expectations regarding the timing of the Livermore Production Campus (Forge 1) becoming fully operational and its expected manufacturing capacity, role as the Company’s primary production and manufacturing center, delivery timelines, and cost benefits, the expected benefits of the Company’s participation in the Government-Industry Data Exchange Program and its recent leadership appointments, the Company’s expectations regarding the development, introduction, timing and anticipated benefits of new products, including expected improvements in productivity, output per printer and cost, the Company’s expectations regarding its potential cost savings, the Company’s expectations about its market strategy and financial and operational position, the Company’s expectations that the RPS parts production business will contribute an increasing share of revenue, and the Company’s other expectations, beliefs, intentions or strategies for the future. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. You should carefully consider the risks and uncertainties described in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “FY 2025 10-K”) and its Quarterly Reports on Form 10-Q (“Quarterly Reports”), including its Quarterly Report on Form 10-Q for the quarter ended September 30, 2026 to be filed with the SEC, and the other documents filed by the Company from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Most of these factors are outside the Company’s control and are difficult to predict. Factors that may cause such differences include, but are not limited to: (1) the inability of the Company to execute its business plan, which may be affected by, among other things, competition, the Company’s liquidity position, the ability of the Company to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its key employees; (2) whether the Company’s existing cash and cash equivalents will be sufficient to fund its operating expenses and capital expenditure requirements, and the Company’s ability to continue as a going concern; (3) the Company’s ability to service and comply with its indebtedness; (4) the Company’s ability to raise additional capital on acceptable terms, or at all; (5) the Company’s ability to equip, commission, qualify and ramp Forge 1 on the expected timeline and budget, and the risk of operating Forge 1 below capacity given its fixed lease and operating costs; (6) the impact of tariffs, supplier pricing and credit terms on the Company’s cost of revenue and gross margin, and the risk that gross margin will vary from period to period, including as a result of inventory-related adjustments; (7) the Company’s dependence on a limited number of customers for a significant portion of its revenue; (8) the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; (9) the risk that future sales of common stock, including sales under the Company’s at-the-market offering program, will dilute existing stockholders and may adversely affect the market price of the Company’s common stock; (10) changes in the applicable laws and regulations; (11) risks related to the Company’s exposure to government and defense contracts, including potential delays or reductions in government funding, government shutdowns, changes in defense procurement priorities or spending levels, and the timing and uncertainty of government contract awards and modifications; (12) the risk that the Company’s backlog and bookings may not convert into revenue on the timelines the Company expects, or at all; (13) the Company’s ability to remediate the remaining material weaknesses in its internal control over financial reporting; (14) the risk that the Company may not achieve its financial guidance for fiscal year 2026, or its expectations regarding positive EBITDA and positive net cash provided by operating activities in 2028, and that actual results may differ materially from, or that the Company may revise, such guidance or expectations; and (15) other risks and uncertainties described in the FY 2025 10-K and the Quarterly Reports, including those under “Risk Factors” therein, and in the Company’s other filings with the SEC. The Company cautions that the foregoing list of factors is not exclusive and cautions readers not to place undue reliance upon any forward-looking statements, including projections, which speak only as of the date made. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by applicable law.

Non-GAAP Financial Information

The information in the table below sets forth the non-GAAP financial measures that the Company uses in this release. Because of the inherent limitations associated with these non-GAAP financial measures, “Non-GAAP Net Loss”, “Non-GAAP net loss per basic and diluted share”, “EBITDA”, “Adjusted EBITDA” and “Non-GAAP Adjusted Operating Expenses”, should not be considered in isolation or as a substitute for performance measures calculated in accordance with GAAP. In addition, these non-GAAP financial measures may differ from, and should not be compared to, similarly named measures used by other companies. The Company compensates for these limitations by relying primarily on its GAAP results and using Non-GAAP Net Loss, Non-GAAP net loss per basic and diluted share, EBITDA, Adjusted EBITDA, and Non-GAAP Adjusted Operating Expenses on a supplemental basis. You should review the reconciliation of the non-GAAP financial measures below and not rely on any single financial measure to evaluate the Company’s business.

Management uses “Non-GAAP Net Loss”, “Non-GAAP net loss per basic and diluted share”, “EBITDA”, “Adjusted EBITDA” and “Non-GAAP Adjusted Operating Expenses” to evaluate operating performance, prepare budgets and forecasts, and evaluate performance for compensation purposes. Management believes these measures are useful to investors because they allow for comparison to the Company’s performance in prior periods without the effect of items that, by their nature, tend to obscure the Company’s core operating results due to potential variability across periods based on the timing, frequency and magnitude of such items. As a result, management believes that these measures enhance the ability of investors to analyze trends in the Company’s business and evaluate the Company’s performance relative to peer companies.

Reconciliations of the differences between these non-GAAP financial measures and their most directly comparable financial measures calculated in accordance with GAAP are set forth below.

The Company’s non-GAAP adjusted operating expenses are calculated by excluding stock-based compensation recorded in operating expenses. The Company’s EBITDA is calculated as net loss excluding interest expense, provision for (benefit from) income taxes, and depreciation and amortization. Adjusted EBITDA further excludes stock-based compensation, loss on warrant cancellation, fair value adjustments for the Company’s warrants and earnout liability. With respect to the Company’s guidance regarding non-GAAP adjusted operating expenses for 2026 and EBITDA for 2028, the Company cannot provide, without unreasonable effort, a quantitative reconciliation to the most directly comparable GAAP measures, operating expenses and net loss, respectively, because it cannot predict with reasonable certainty certain items needed to calculate such measures, including stock-based compensation expense, which depends on future grants and the price of the Company’s common stock, and interest income and expense, income taxes and depreciation and amortization associated with the timing of future capital expenditures. These items could have a significant impact on the Company’s GAAP results.

Velo3D, Inc.

Non-GAAP Net Loss Reconciliation

(Unaudited)

 

Three months ended

Nine months ended

September 30, 2026

September 30, 2025

September 30, 2026

September 30, 2025

($ In thousands)

Revenue

$

20,450

$

13,640

$

54,930

$

36,532

Gross profit (loss)

5,418

433

14,369

(458)

Net Loss

$

(16,692)

$

(11,188)

$

(33,608)

$

(49,465)

Stock-based compensation

5,928

1,905

10,311

7,335

(Gain) loss on fair value of warrants

(68)

—

(27)

1,044

Gain on fair value of contingent earnout

(1)

—

(1)

—

Loss on warrant cancellation

—

—

—

11,357

Non-GAAP Net Loss

$

(10,833)

$

(9,283)

$

(23,325)

$

(29,729)

 

Velo3D, Inc.

Non-GAAP Adjusted EBITDA Reconciliation

(Unaudited)

 

Three months ended

Nine months ended

September 30, 2026

September 30, 2025

September 30, 2026

September 30, 2025

($ In thousands)

Revenue

$

20,450

$

13,640

$

54,930

$

36,532

Net Loss

(16,692)

(11,188)

(33,608)

(49,465)

Interest expense

160

1,198

1,068

3,840

Provision for (benefit from) income taxes

(21)

(14)

(4)

83

Depreciation and amortization

884

813

2,358

2,630

EBITDA

$

(15,669)

$

(9,191)

$

(30,186)

$

(42,912)

Stock-based compensation

5,928

1,905

10,311

7,335

(Gain) loss on fair value of warrants

(68)

—

(27)

1,044

Gain on fair value of contingent earnout

(1)

—

(1)

—

Loss on warrant cancellation

—

—

—

11,357

Non-GAAP Adjusted EBITDA

$

(9,810)

$

(7,286)

$

(19,903)

$

(23,176)

 

Velo3D, Inc.

Non-GAAP Adjusted Operating Expenses Reconciliation

(Unaudited)

 

Three months ended

Nine months ended

September 30, 2026

September 30, 2025

September 30, 2026

September 30, 2025

($ In thousands)

Revenue

$

20,450

$

13,640

$

54,930

$

36,532

Operating expenses

Research and development

5,387

2,722

12,948

7,369

Selling and marketing

3,178

1,797

7,749

4,351

General and administrative

14,141

5,907

27,377

20,934

Total operating expenses

$

22,706

$

10,426

$

48,074

$

32,654

Stock-based compensation recorded in operating expenses

5,696

1,310

9,332

5,933

Non-GAAP Adjusted operating expenses

$

17,010

$

9,116

$

38,742

$

26,721

 

Velo3D, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(In thousands, except share and per share data)

 

The three months ended September 30,

The nine months ended September 30,

2026

2025

2026

2025

Revenue

3D Printer and parts

$

18,832

$

11,993

$

49,821

$

31,598

Recurring payment

—

—

—

70

Support services

1,411

1,351

4,174

4,500

Other

207

296

935

364

Total Revenue

20,450

13,640

54,930

36,532

Cost of revenue

3D Printer and parts

13,950

11,855

37,802

33,389

Recurring payment

—

—

—

12

Support services

1,082

1,352

2,759

3,589

Total cost of revenue

15,032

13,207

40,561

36,990

Gross profit (loss)

5,418

433

14,369

(458)

Operating expenses

Research and development

5,387

2,722

12,948

7,369

Selling and marketing

3,178

1,797

7,749

4,351

General and administrative

14,141

5,907

27,377

20,934

Total operating expenses

22,706

10,426

48,074

32,654

Loss from operations

(17,288)

(9,993)

(33,705)

(33,112)

Interest expense

(160)

(1,198)

(1,068)

(3,840)

Gain (loss) on fair value of warrants

68

—

27

(1,044)

Gain on fair value of contingent earnout liabilities

1

—

1

—

Loss on warrant cancellation

—

—

—

(11,357)

Other income (expense), net

666

(11)

1,133

(29)

Loss before income taxes

(16,713)

(11,202)

(33,612)

(49,382)

Provision for (benefit from) income taxes

(21)

(14)

(4)

83

Net loss

$

(16,692)

$

(11,188)

$

(33,608)

$

(49,465)

Net loss per share:

    Basic and Diluted

$

(0.52)

$

(0.65)

$

(1.16)

$

(3.33)

Shares used in computing net loss per share:

    Basic and Diluted

32,199,624

17,124,361

28,915,965

14,868,372

 

Velo3D, Inc.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In thousands, except share and per share data)

 

September 30,

December 31,

2026

2025

Assets

Current assets:

Cash and cash equivalents

$

75,732

$

39,013

Accounts receivable, net

8,658

6,263

Inventories, net

30,765

27,083

Contract assets

16,303

2,039

Prepaid expenses and other current assets

12,963

5,722

Total current assets

144,421

80,120

Property and equipment, net

23,216

13,094

Equipment subject to operating lease, net

494

1,629

Other assets

84,174

10,505

Total assets

$

252,305

$

105,348

Liabilities and Stockholders’ Equity

Current liabilities:

Accounts payable

$

6,440

$

10,301

Accrued expenses and other current liabilities

7,702

7,915

Debt – current portion

3,261

6,305

Contract liabilities

10,788

9,281

Total current liabilities

28,191

33,802

Long-term debt – less current portion

4,135

24,710

Contingent earnout liabilities

—

1

Warrant liabilities

81

109

Other noncurrent liabilities

82,595

8,570

Total liabilities

115,002

67,192

Stockholders’ equity:

Common stock, $0.00001 par value — 500,000,000 shares authorized at September 30, 2026 and December 31, 2025, respectively, 32,260,870 and 24,607,630 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively

5

5

Additional paid-in capital

669,049

536,294

Accumulated deficit

(531,751)

(498,143)

Total stockholders’ equity

137,303

38,156

Total liabilities and stockholders’ equity

$

252,305

$

105,348

 

Velo3D, Inc.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(In thousands)

 

The nine months ended September 30,

2026

2025

Cash flows from operating activities

Net loss

$

(33,608)

$

(49,465)

Adjustments to reconcile net loss to net cash used in operating activities

Depreciation and amortization

2,358

2,630

Amortization of debt discount and deferred financing costs

17

148

Stock-based compensation

10,311

7,335

(Gain) loss on fair value of warrants

(27)

1,044

Gain on fair value of contingent earnout liabilities

(1)

—

Loss on warrant cancellation

—

11,357

Reserve for excess and obsolete inventory

1,948

—

Provision for credit losses

57

37

Non-cash lease expense

156

105

Loss on sale/disposal of fixed assets

—

24

Changes in operating assets and liabilities

Accounts receivable

(2,452)

(2,986)

Inventories

(3,177)

11,333

Contract assets

(14,264)

(2,938)

Prepaid expenses and other current assets

(7,241)

507

Other assets

871

(5,890)

Accounts payable

(10,052)

(1,762)

Accrued expenses and other liabilities

(1,543)

11,876

Contract liabilities

1,507

(2,057)

Other noncurrent liabilities

2,947

(888)

Net cash used in operating activities

(52,193)

(19,590)

Cash flows from investing activities

Purchase of property and equipment

(6,375)

(2,112)

Net cash used in investing activities

(6,375)

(2,112)

Cash flows from financing activities

Proceeds from convertible secured notes

—

15,000

Gross proceeds from April 2026 Offering

50,000

—

Payment for issuance costs related to April 2026 Offering

(3,408)

—

Gross proceeds from ATM Offering

59,428

—

Payment for issuance costs related to ATM Offering

(2,070)

—

Gross proceeds from August 2025 Offering

—

20,125

Payment for issuance cost related to August 2025 Offering

—

(2,303)

Repayment of 2025 equipment loan

(2,282)

—

Repayment of secured notes

(3,039)

(499)

Net cash provided by financing activities

98,629

32,323

Effect of exchange rate changes on cash and cash equivalents

6

4

Net change in cash and cash equivalents and restricted cash

40,067

10,625

Cash and cash equivalents and restricted cash at beginning of period

39,636

1,840

Cash and cash equivalents and restricted cash at end of period

$

79,703

$

12,465

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets to the total of such amounts shown on the condensed consolidated statements of cash flows:

The nine months ended September 30,

2026

2025

Cash and cash equivalents

$

75,732

$

11,842

Restricted cash (Other assets)

3,971

623

Total cash and cash equivalents and restricted cash

$

79,703

$

12,465

View original content to download multimedia:https://www.prnewswire.com/news-releases/velo3d-announces-third-quarter-2026-financial-results-302935529.html

SOURCE Velo3D, Inc.

Continue Reading

Technology

Elsevier’s ClinicalKey AI combines world-leading content and patient-specific information to set a new standard in clinical decision support

Published

on

By

ClinicalKey AI offers integration of point-of-care AI, market-leading content and the patient’s medical record across different EHR platforms

NEW YORK, Nov. 16, 2026 /PRNewswire/ — Elsevier’s ClinicalKey AI, a trusted point-of-care tool used by clinicians throughout the U.S. can now access a patient’s entire medical record inside the Electronic Health Record (EHR) and evaluate treatment plans against the company’s evidence-based clinical content. Used in more than 1,200 hospital sites across the world, ClinicalKey AI not only integrates point-of-care AI with all EHR providers, it does so with the security health systems are looking for as they protect patient data and adopt responsible AI use. This follows Elsevier’s acquisition in June 2026 of Wellsheet, a U.S.-based health technology company that specializes in aggregating and synthesizing patient data from electronic health records (EHR) to surface relevant clinical intelligence at the point of care.

When providers use ClinicalKey AI, it starts with the patient, not a blank AI prompt. The solution provides clinical decision support that is highly personalized; directly in the clinicians’ workflows at the point of care. Every answer includes data from the patient’s chart and citations from trusted content – ClinicalKey AI draws answers from full text articles from approximately 1,000 world leading journals.

Elsevier is working with health systems across the U.S., including centers like the San Juan Regional Medical Center in New Mexico which serves communities with limited access to healthcare. With this new offering, ClinicalKey AI sets a new standard for evidence-based clinical decision making by bringing trusted clinical knowledge and relevant patient context together within the clinical workflow, providing critical support to health systems.

Dr. Carlo Hallak, Physician Executive at SJRMC, said: “We’re already seeing how ClinicalKey AI can be instrumental at the bedside and help improve care for our patients. As a rural healthcare center, we are proud to say that by using ClinicalKey AI to check each patient’s care against the same evidence base that major health systems rely on, we’re able to deliver the standard of care patients expect in any major city or leading academic center. ClinicalKey AI reads the whole chart, checks it against the evidence and shows exactly where each finding comes from. That support is invaluable for a hospital like ours, and we’re already seeing strong adoption of ClinicalKey AI among our clinicians.”

San Juan Regional Medical Center is utilizing ClinicalKey AI’s new patient context functionality to provide quality care with fewer resources. With smaller clinical and quality teams than large academic health systems, and in a state where nearly 40% of residents rely on Medicaid, the medical center has found this support especially valuable.

Omry Bigger, President of Clinical Solutions at Elsevier, said: “Health systems tell us two things stand in the way of adopting AI: tools that don’t work with their existing EHR partners, and concerns about security, compliance and responsible use. ClinicalKey AI was designed to address both. As an EHR supported and HIPAA compliant ready solution, ClinicalKey AI integrates seamlessly across health systems to provide clinicians with trusted evidence and patient context that gives them tailored clinical insights for each patient at the point of care.”

Find out more about ClinicalKey AI here or by visiting us at the HLTH Conference (Booth 3518) in Las Vegas from November 15-18.

About San Juan Regional Medical Center 

San Juan Regional Medical Center is a not-for-profit, community-governed acute care medical center located in Farmington, New Mexico. Committed to bettering the quality of life, health, and care of its community, SJRMC offers a broad range of inpatient, outpatient, and emergency services, along with primary and specialty care, to patients across the Four Corners region. For more information, visit www.sanjuanregional.com.

About Elsevier

Elsevier is a global leader in advanced information and decision support. For over a century, we have been helping advance science and healthcare to advance human progress. We support academic and corporate research communities, doctors, nurses, future healthcare professionals, and educators across 170 countries in their vital work. We help impact makers achieve better outcomes with research and clinical-grade solutions built on the world’s leading evidence-based scientific and medical content, precision AI, and expert human assessment. We champion inclusion and sustainability, working with the communities that we serve. The Elsevier Foundation supports research and health partnerships around the world.

Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. For more information, visit www.elsevier.com and follow us on social media @elsevierconnect.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/elseviers-clinicalkey-ai-combines-world-leading-content-and-patient-specific-information-to-set-a-new-standard-in-clinical-decision-support-302940260.html

Continue Reading

Technology

ADP to Present at Upcoming Investor Conference

Published

on

By

ROSELAND, N.J., Nov. 16, 2026 /PRNewswire/ — ADP (Nasdaq: ADP), a global leader in HR and payroll solutions, today announced that it will present at the Nasdaq Investor Conference in London on Tuesday, December 8, 2026 at 4:00 a.m. ET / 9:00 a.m. GMT. 

Links to the live webcast and an archived replay of the event will be available on ADP’s website at investors.adp.com.

About ADP (Nasdaq: ADP)
ADP has been shaping the world of work with innovation and expertise for more than 75 years. As a global leader in HR and payroll solutions, ADP continuously works to solve business challenges for our clients and their workers, from simple, easy-to-use tools for small businesses to fully integrated platforms for global enterprises – and everything in between. Always Designing for People means we’re focused on just that – people. We use our unmatched AI-driven insights and proven expertise to design innovative solutions that help people achieve greater success at work. More than 1.1 million clients across 140+ countries rely on ADP’s exceptional service to support their people and drive their business forward. HR, Talent, Time Management, Benefits, Compliance, and Payroll. Learn more at ADP.com

ADP, the ADP logo, and Always Designing for People are trademarks of ADP, Inc.

Copyright © 2026 ADP, Inc. All rights reserved.

ADP – Investor Relations

Investor Relations Contacts:
Matthew Keating, CFA
973.974.3037
Matthew.Keating@adp.com

ADP – Media

Media Contact:
Allyce Hackmann
201.400.4583
Allyce.Hackmann@adp.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/adp-to-present-at-upcoming-investor-conference-302939068.html

SOURCE ADP – IR

Continue Reading

Technology

ZUERST Flextri F5 Gains Momentum in China with a Three-in-One Foldable Design for Phones, Tablets and Laptops

Published

on

By

SHENZHEN, China, Nov. 16, 2026 /PRNewswire/ — 3C digital accessory manufacturer ZUERST is bringing its Flextri F5 three-in-one foldable stand to greater international attention following its growing sales performance in China. Through a versatile folding structure, ZUERST Flextri F5 combines multiple device-support modes (phone stand mode, tablet stand mode and laptop stand mode) in one compact stand. It offers a more flexible device-support solution for work, study and everyday use.

Meeting the Needs of a Multi-Device Lifestyle

Nowadays, people’s needs regarding electronic devices and their usage environments are evolving. For users who rely on smartphones, tablets, and laptops to handle various tasks, carrying and setting up separate stands for each device can take up excessive desk space and prove inconvenient when on the go. Consequently, stands that accommodate multiple types of devices—offering both flexibility and portability—have become a practical solution for multi-device users.

ZUERST developed the Flextri F5 around this practical need. Its three-in-one design brings phone stand, tablet stand and laptop stand functions together in one foldable product. Rather than offering three separate accessories, the Flextri F5 uses a multi-joint folding structure to switch between different support configurations.

“We think good product design is about meeting everyday needs in smarter ways. With the Flextri F5, we have integrated three device-support modes into one well-designed folding structure, offering greater flexibility for people who use multiple electronic devices today.” said Huifeng Chen, the founder of ZUERST.

One Stand, Three Modes: The Design Behind Flextri F5

ZUERST Flextri F5 adapts to different devices and tasks through three use modes. In phone stand mode, it provides a stable platform for video calls, viewing content and hands-free operation, and offers two adjustable angles. In tablet stand mode, it is suitable for reading, note-taking, online learning and entertainment. Its laptop stand mode supports six adjustable angles (12° to 31°), allowing users to adjust the screen angle according to different usage habits, making it suitable for desk work, remote work and other productivity-focused settings.

The product’s core feature is its multi-joint folding structure, which allows users to switch the stand between three configurations. When opened, its double-triangle support structure provides stable support for the device; when folded, it measures 149 × 82 × 12 mm and weighs only 300 g. So it can be easily tucked into a pocket, backpack, or laptop bag, making it ideal for commuting, business travel and shared workspace.

In terms of materials, ZUERST Flextri F5 uses an aluminum alloy main structure with a maximum load capacity of 10 kg, maintaining a lightweight appearance while ensuring the structural strength required for daily use. High-strength anti-slip silicone pads cover all contact points on the product to help prevent slipping and protect device surfaces from scratches.

Flextri F5’s Market Growth Reflects ZUERST’s Design Approach

Since its launch in May 2026, ZUERST Flextri F5 has achieved growth in sales in China, with channels covering Chinese e-commerce platforms such as Tmall, Douyin, WeChat stores, RedNote, as well as the brand’s own channels.

As of October, ZUERST Flextri F5 had accumulated sales of 21,418 units on Chinese e-commerce platforms. October sales reached 9,368 units, representing an approximately 71.5% increase compared to September and more than seven times the sales volume in July. This performance reflects the product’s growing market acceptance in China and demonstrates the value of its three-in-one design in multi-device usage scenarios.

The Flextri F5 also reflects ZUERST’s broader design approach to electronic device accessories. “We firmly believe that true product innovation should not stop at changes in appearance. It should start from the product structure itself, rethinking its function, form, and usage.” Chen added. ZUERST emphasizes original product design, structural innovation, and practical applications, continuously exploring the application of support structures, mechanical connections, and folding mechanisms in electronic device accessories, striving to achieve a balance between product stability, space utilization, and portability. Currently, it holds 40 patents across different jurisdictions and various patent categories.

As a laptop and tablet stand manufacturer, ZUERST also develops accessories for various electronic devices, including wireless chargers, headphone stands, and office keyboards. Looking ahead, ZUERST will continue to explore how structural design can turn everyday accessories into more adaptable tools for modern work and life.

About ZUERST

Founded in 2017, ZUERST is a brand of Shenzhen Reno Information Technology Co., Ltd., which specializes in the R&D, production, and OEM/ODM manufacturing of 3C digital accessories, including laptop stands, phone stands, tablet stands, headphone stands and wireless chargers. The company holds the ISO 9001 quality management certification, and some of its products comply with applicable CE, RoHS and REACH requirements. Today, ZUERST serves clients in over 100 countries and regions worldwide.

Media Contact:

Reno Information Technology Co., Ltd.
Building 13, Zone B, Liantang Industrial Zone, Shangcun Community, Gongming Street, Guangming District, Shenzhen, Guangdong, China
Email: office@sz-zuerst.com
Tel: +86 13823636803
www.sz-zuerst.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/zuerst-flextri-f5-gains-momentum-in-china-with-a-three-in-one-foldable-design-for-phones-tablets-and-laptops-302940160.html

SOURCE Reno Information Technology Co., Ltd.

Continue Reading

Trending